AbbVie Inc. (ABBV) Stock Overview
Explore AbbVie Inc.’s financial performance, market position, analyst ratings, and future outlook.
AbbVie Inc. (ABBV)
Key Financials
Key Financials
Market Cap
401.3B
P/E Ratio
111.13
EPS (TTM)
$2.04
ROE
0.68%
ABBV Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of AbbVie Inc. (ABBV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 68.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $237.10.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 111.13 and a market capitalization of 401.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.